- Home
- SLNO vs DEI Comparison
SLNO vs DEI Comparison
Compare SLNO & DEI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SLNO | DEI |
|---|---|---|
| Founded | 1999 | 1971 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 1.9B |
| IPO Year | 2014 | 2006 |
Fundamental Metrics
Financial Performance| Metric | SLNO | DEI |
|---|---|---|
| Price | $38.33 | $10.35 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 11 | 9 |
| Target Price | ★ $109.82 | $13.50 |
| AVG Volume (30 Days) | 1.3M | ★ 2.9M |
| Earning Date | 05-29-2026 | 05-12-2026 |
| Dividend Yield | N/A | ★ 7.58% |
| EPS Growth | ★ 108.90 | N/A |
| EPS | ★ 0.39 | 0.09 |
| Revenue | $1,450,788.00 | ★ $1,003,982,000.00 |
| Revenue This Year | $158.91 | $2.59 |
| Revenue Next Year | $54.20 | $1.94 |
| P/E Ratio | ★ $98.00 | $110.56 |
| Revenue Growth | ★ 138.82 | 1.77 |
| 52 Week Low | $32.63 | $9.29 |
| 52 Week High | $89.12 | $17.42 |
Technical Indicators
Market Signals| Indicator | SLNO | DEI |
|---|---|---|
| Relative Strength Index (RSI) | 43.08 | 50.04 |
| Support Level | $38.17 | $9.53 |
| Resistance Level | $44.60 | $11.45 |
| Average True Range (ATR) | 2.39 | 0.45 |
| MACD | 0.10 | 0.03 |
| Stochastic Oscillator | 61.70 | 81.54 |
Price Performance
Historical ComparisonAbout SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.
About DEI Douglas Emmett Inc.
Douglas Emmett Inc is an integrated, self-administered, and self-managed REIT. It is an owner and operator of office and multifamily properties located in coastal submarkets in Los Angeles and Honolulu. The group focuses on owning, acquiring, developing, and managing a substantial market share of office properties and multifamily communities in neighborhoods with supply constraints, high-end executive housing, and key lifestyle amenities. Its properties are located in the Beverly Hills, Brentwood, Burbank, Century City, Olympic Corridor, Santa Monica, Sherman Oaks/Encino, Warner Center/Woodland Hills and Westwood submarkets of Los Angeles County, California, and in Honolulu, Hawaii. It has two business segments, the office segment and the multifamily segment.